LARS2 Antikörper (Middle Region)
Kurzübersicht für LARS2 Antikörper (Middle Region) (ABIN953140)
Target
Alle LARS2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 425-453, Middle Region
-
Spezifität
- This antibody recognizes Human LARS2 (Center).
-
Aufreinigung
- Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS
-
Immunogen
- KLH conjugated synthetic peptide between 425-453 amino acids from the Central region of Human LARS2.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- LARS2 (Leucyl-tRNA Synthetase 2, Mitochondrial (LARS2))
-
Andere Bezeichnung
- LARS2
-
Hintergrund
- This gene encodes a class 1 aminoacyl-tRNA synthetase, mitochondrial leucyl-tRNA synthetase. Each of the twenty aminoacyl-tRNA synthetases catalyzes the aminoacylation of a specific tRNA or tRNA isoaccepting family with the cognate amino acid.Synonyms: EC=6.1.1.4, KIAA0028, LARS2, LeuRS, Leucine-tRNA ligase, Leucyl-tRNA synthetase, mitochondrial
-
Molekulargewicht
- 101976 Da
-
Gen-ID
- 23395
-
NCBI Accession
- NP_056155
Target
-